Clinical Trial Update: Acute Myocardial Necrosis and Depression: Antiplatelet Effect of Reuptake Inhibition of Serotonin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating whether serotonin reuptake inhibition has antiplatelet effects in patients with depression and coronary artery disease, ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Major Depressive Disorder

Drugs mentioned

• Unspecified SSRI (serotonin reuptake inhibitor)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Depression, Coronary Artery Disease | Phase 4 | Status: TERMINATED